Clinical Trial Update: ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial [Phase 2, Phase 3]

View source ↗

Summary

An open-label Phase 2/3 clinical trial evaluating ACTHAR Gel for cutaneous sarcoidosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Sarcoidosis
• Sarcoidosis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Albany Medical College | Conditions: Sarcoidosis, Cutaneous Sarcoidosis | Phase 2, Phase 3 | Status: UNKNOWN